Spironolactone Tablet
Product Images NDC 60687-476

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 60687-476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Blister

Spironolactone Tablet USP 100 mg oral tablet label by American Health Packaging. The label includes the product name, strength, dosage form, lot number 1234567, and expiry date 02/22. Barcodes and manufacturer information are also visible on the label.*

FDA Label Image

100 mg Carton

Spironolactone 100 mg Tablets, USP oral dosage form in a package of 100 tablets (10 x 10). The label shows American Health Packaging as the labeler and includes the NDC number 60687-487-01. The label specifies Rx Only and includes storage instructions, drug content, and distribution details from Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

25 mg Blister

Spironolactone Tablet, USP 25 mg oral tablets are presented in a sheet with six individual doses. Each dose label includes the product name, strength, lot number 1234567, and expiration date 02/22. The labeler is American Health Packaging, Columbus, OH 43217. Barcode and product identifiers are also visible on each label.*

FDA Label Image

25 mg Carton

Spironolactone 25 mg tablets label by American Health Packaging. The label shows two identical sections, each indicating 100 tablets (10 x 10) in oral tablet form. It includes storage instructions, a warning to keep out of reach of children, and distributor information from American Health Packaging, Columbus, Ohio. The label features the NDC number 60687-465-01 and barcode.*

FDA Label Image

50 mg Blister

Label sheet for Spironolactone tablets USP 50 mg from American Health Packaging. Each label includes the product name, strength, dosage form, a barcode, and space for lot number and expiration date. Labels are arranged in pairs in multiple rows.*

FDA Label Image

50 mg Carton

Label for Spironolactone 50 mg tablets, USP, with 100 tablets (10 x 10) per package. The label includes the NDC number 60687-476-01 and indicates prescription use only. Distributed by American Health Packaging, Columbus, Ohio. The image also shows a secondary label with storage instructions, protective measures, and drug product source information.*

FDA Label Image

Ahp46501

Spironolactone 25 mg oral tablet imprinted with '660' on one side and blank on the other. The round, white tablet is part of American Health Packaging's prescription drug line for oral use.*

FDA Label Image

Ahp47601

Spironolactone 25 mg oral tablet, white, oval with score line on both sides, imprinted with '551' on one side. Manufactured by American Health Packaging.*

FDA Label Image

Ahp48701

Spironolactone 50 mg tablet, round and white, with imprint '562' on one side and a scored line on the other. Oral tablet form manufactured by American Health Packaging.*

FDA Label Image

Figure 1

A Kaplan-Meier survival curve comparing probability over months between Spironolactone (n=822) and placebo (n=841) groups. The graph shows higher survival probability for Spironolactone group with a log-rank p-value less than 0.001.*

FDA Label Image

Figure 2

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4 showing relative effect favoring spironolactone or placebo.*

FDA Label Image

Structure

Chemical structure diagram of spironolactone, showing its steroidal ring system with attached functional groups including a lactone ring and thioacetate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.